ClinicalTrials.Veeva

Find clinical trials for Lung Cancer in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near San Francisco, CA, USA:

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...

Enrolling
Metastatic Non-small Cell Lung Cancer
Drug: Osimertinib
Drug: Carboplatin

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

San Francisco, California, United States and 14 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Francisco, California, United States and 30 other locations

with osimertinib in treating patients with EGFR-mutated stage IV lung cancer. Alisertib may stop the growth of tumor cells by block ...

Active, not recruiting
Lung Cancer Metastatic
EGFR Gene Mutation
Drug: Alisertib
Drug: Osimertinib

Phase 1

Collin Blakely

San Francisco, California, United States

Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before surgery. Osimertinib may stop the growth of tumo...

Active, not recruiting
Stage IA Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Drug: Osimertinib
Procedure: Therapeutic Conventional Surgery

Phase 2

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States and 2 other locations

, early-stage non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: Cisplatin
Drug: Oleclumab

Phase 2

AstraZeneca
AstraZeneca

Oakland, California, United States and 94 other locations

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

Stanford, California, United States and 25 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 137 other locations

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...

Active, not recruiting
Small Cell Lung Cancer
Drug: Durvalumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 181 other locations

of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung...

Enrolling
Limited-Stage Small Cell Lung Cancer
Radiation: Thoracic radiotherapy
Drug: carboplatin/cisplatin-etoposide

Phase 3

Henlius Pharmaceuticals

Santa Rosa, California, United States and 128 other locations

with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or hormone receptor positive (HR+), human epide....

Active, not recruiting
Breast Cancer
Non Small Cell Lung Cancer
Drug: Abemaciclib
Drug: Pembrolizumab

Phase 1

Lilly
Lilly

San Francisco, California, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems